The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical composition containing them.
Ruat, M., Fraure, H., Traiffort, E., Schoenfelder, A., Mann, A., Solinas, A., et al. (2009)N-Acylthiourees et N-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog. . Brevetto No. WO2009130422.
N-Acylthiourees et N-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
TADDEI, MAURIZIO;MANETTI, FABRIZIO
2009-01-01
Abstract
The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical composition containing them.
| File | Dimensione | Formato | |
|---|---|---|---|
|
WO2009130422A2_HhInhib.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
2.8 MB
Formato
Adobe PDF
|
2.8 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/45238
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo